• Product nameAnti-KCNQ3 antibody
    See all KCNQ3 primary antibodies
  • Description
    Rabbit polyclonal to KCNQ3
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse
    Predicted to work with: Rat, Rabbit, Horse, Guinea pig, Human
  • Immunogen

    Synthetic peptide: TPKHKKSQKG SAFTYPSQQS PRNEPYVARA ATSETEDQSM MGKFVKVERQ, corresponding to internal sequence amino acids 580-629 of Human KCNQ3

  • Positive control
    • Mouse heart lysate


  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferConstituents: 98% PBS, 2% Sucrose
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab113948 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 97 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.


  • FunctionProbably important in the regulation of neuronal excitability. Associates with KCNQ2 or KCNQ5 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs.
  • Tissue specificityPredominantly expressed in brain.
  • Involvement in diseaseDefects in KCNQ3 are the cause of benign neonatal epilepsy type 2 (EBN2) [MIM:121201]. Benign neonatal epilepsy is characterized by clusters of seizures occurring in the first days of life. Most patients have spontaneous remission by 12 months of age and show normal psychomotor development. The disorder is distinguished from benign familial infantile seizures by an earlier age at onset.
  • Sequence similaritiesBelongs to the potassium channel family. KQT (TC 1.A.1.15) subfamily. Kv7.3/KCNQ3 sub-subfamily.
  • DomainThe segment S4 is probably the voltage-sensor and is characterized by a series of positively charged amino acids at every third position.
  • Cellular localizationMembrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • BFNC 2 antibody
    • BFNC antibody
    • BFNC2 antibody
    • EBN 2 antibody
    • EBN2 antibody
    • KCNQ 3 antibody
    • KCNQ3 antibody
    • KCNQ3_HUMAN antibody
    • KQT like 3 antibody
    • KQT-like 3 antibody
    • KV7.3 antibody
    • Potassium channel subunit alpha KvLQT3 antibody
    • Potassium channel voltage gated subfamily Q member 3 antibody
    • Potassium voltage gated channel KQT like protein 3 antibody
    • Potassium voltage gated channel KQT like subfamily member 3 antibody
    • Potassium voltage gated channel subfamily KQT member 3 antibody
    • Potassium voltage-gated channel subfamily KQT member 3 antibody
    • Voltage gated potassium channel subunit Kv7.3 antibody
    • Voltage-gated potassium channel subunit Kv7.3 antibody
    see all

Anti-KCNQ3 antibody images

  • Predicted band size : 97 kDa
    Western blot analysis of CHO cell lysate (100µg) labeling KCNQ3 with ab113948 with 1:1000. AHRP-conjugated Goat anti-rabbit IgG (1:25000) was used as the secondary antibody.
  • Anti-KCNQ3 antibody (ab113948) at 1 µg/ml + Mouse heart lysate at 10 µg

    Predicted band size : 97 kDa
    Gel concentration: 6-18%

References for Anti-KCNQ3 antibody (ab113948)

ab113948 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab113948.
Please use the links above to contact us or submit feedback about this product.